Company / Gross Margin
AMICUS THERAPEUTICS, INC. Gross Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
88.5%
FY2025
5-year range
88.3% / 90.6%
FY2021-FY2025
Trend
-1.6%
vs FY2024
Sector context
#3 of 28
Health Care
What the data says
AMICUS THERAPEUTICS, INC.'s gross margin of 88.5% is higher than 89% of companies in the Health Care sector (FY2025). Gross Margin remained relatively stable over the past 9 years, with values between 83.1% and 90.6%.
Based on SEC 10-K filings.
88.5% in FY2025 with a 5-year CAGR of +0.4%. Ranks 3rd among 28 companies in Health Care.
Declined from 90.6% to 88.5% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- +0.2pp
- 5-Year Change
- +0.4pp
- 10-Year Change
- -
Sector benchmark
Top 11% in Health CareTop 11% of 28This company 88.5% Sector average 60.3%
▼
+46.8% above sector average
Key checks
Key Insights
- In FY2025, gross margin decreased 1.6% year-over-year.
- Currently 28.2pp above the Health Care sector average.
- Peak gross margin was recorded in FY2023.
- Lowest gross margin in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -1.19 (distress zone, below 1.8 threshold)
- Negative profit margin: -10.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 88.5% | -1.6% |
| FY2024 | 90.0% | -0.7% |
| FY2023 | 90.6% | +2.7% |
| FY2022 | 88.3% | -0.5% |
| FY2021 | 88.7% | +0.7% |
| FY2020 | 88.1% | +0.2% |
| FY2019 | 87.9% | - |
| FY2018 | - | - |
| FY2017 | 83.1% | -0.1% |
| FY2016 | 83.2% | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026